Vtesse's Series A - II Round

Vtesse raised a round of funding on July 25, 2016.

Vtesse is a rare disease company dedicated to developing drugs for patients suffering from underserved diseases. Vtesse closely collaborates with National Institutes of Health (NIH), parents, patient …

Articles about Vtesse's Series A - II Round: